Healthcare provider profile · identity verified

Sarah Mcelroy

Family Practice · LOCK HAVEN, PA · NPI 1376708487

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	886	219
Omeprazole	Omeprazole	438	116
Lisinopril	Lisinopril	416	114
Amlodipine Besylate	Amlodipine Besylate	406	114
Levothyroxine Sodium	Levothyroxine Sodium	400	113
Eliquis	Apixaban	260	54
Gabapentin	Gabapentin	255	66
Metoprolol Tartrate	Metoprolol Tartrate	255	56
Hydrochlorothiazide	Hydrochlorothiazide	254	76
Metoprolol Succinate	Metoprolol Succinate	233	64
Losartan Potassium	Losartan Potassium	228	59
Potassium Chloride	Potassium Chloride	226	61
Simvastatin	Simvastatin	215	59
Rosuvastatin Calcium	Rosuvastatin Calcium	201	57
Metformin Hcl	Metformin Hcl	200	56
Famotidine	Famotidine	171	54
Furosemide	Furosemide	169	48
Lorazepam	Lorazepam	169	65
Pantoprazole Sodium	Pantoprazole Sodium	150	34
Venlafaxine Hcl Er	Venlafaxine Hcl	122	26
Ozempic	Semaglutide	117	18
Trulicity	Dulaglutide	116	17
Albuterol Sulfate Hfa	Albuterol Sulfate	113	52
Alendronate Sodium	Alendronate Sodium	108	32
Tramadol Hcl	Tramadol Hcl	106	34
Duloxetine Hcl	Duloxetine Hcl	101	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	99	29
Fluticasone Propionate	Fluticasone Propionate	98	51
Glipizide Er	Glipizide	97	25
Montelukast Sodium	Montelukast Sodium	95	31
Citalopram Hbr	Citalopram Hydrobromide	93	26
Telmisartan	Telmisartan	89	24
Ezetimibe	Ezetimibe	86	18
Sertraline Hcl	Sertraline Hcl	84	21
Prednisone	Prednisone	83	53
Tamsulosin Hcl	Tamsulosin Hcl	82	26
Mirtazapine	Mirtazapine	77	12
Pregabalin	Pregabalin	73	22
Meloxicam	Meloxicam	67	25
Carvedilol	Carvedilol	65	15
Synthroid	Levothyroxine Sodium	64	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	62	suppressed
Trazodone Hcl	Trazodone Hcl	62	16
Xarelto	Rivaroxaban	62	13
Allopurinol	Allopurinol	61	20
Clopidogrel	Clopidogrel Bisulfate	60	20
Warfarin Sodium	Warfarin Sodium	59	11
Zolpidem Tartrate	Zolpidem Tartrate	58	19
Jardiance	Empagliflozin	57	15
Escitalopram Oxalate	Escitalopram Oxalate	56	12
Topiramate	Topiramate	56	suppressed
Benazepril Hcl	Benazepril Hcl	54	16
Celecoxib	Celecoxib	54	19
Clonazepam	Clonazepam	54	12
Spironolactone	Spironolactone	54	13
Oxycodone Hcl	Oxycodone Hcl	53	19
Amitriptyline Hcl	Amitriptyline Hcl	51	14
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Lamotrigine	Lamotrigine	49	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	21
Alprazolam	Alprazolam	45	12
Buspirone Hcl	Buspirone Hcl	45	14
Paroxetine Hcl	Paroxetine Hcl	44	14
Metformin Hcl Er	Metformin Hcl	42	14
Myrbetriq	Mirabegron	41	suppressed
Atenolol	Atenolol	39	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	38	suppressed
Valsartan	Valsartan	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	32
Hydroxyzine Hcl	Hydroxyzine Hcl	36	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	29
Januvia	Sitagliptin Phosphate	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Morphine Sulfate Er	Morphine Sulfate	32	suppressed
Naproxen	Naproxen	32	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	12
Doxycycline Hyclate	Doxycycline Hyclate	28	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Glipizide	Glipizide	28	suppressed
Fluconazole	Fluconazole	27	22
Meclizine Hcl	Meclizine Hcl	27	12
Solifenacin Succinate	Solifenacin Succinate	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Rizatriptan	Rizatriptan Benzoate	26	suppressed
Temazepam	Temazepam	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	12
Klor-Con M20	Potassium Chloride	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Azithromycin	Azithromycin	24	18
Nystatin	Nystatin	24	12
Dutasteride	Dutasteride	23	suppressed
Methimazole	Methimazole	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Finasteride	Finasteride	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	12
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Potassium Citrate Er	Potassium Citrate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Estradiol	Estradiol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Baclofen	Baclofen	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Linzess	Linaclotide	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Tirosint	Levothyroxine Sodium	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Cephalexin	Cephalexin	14	13
Eplerenone	Eplerenone	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	12
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Torsemide	Torsemide	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Nuplazid	Pimavanserin Tartrate	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error